scholarly journals Histologically confirmed case of complete atrioventricular block due to hepatocellular carcinoma

2018 ◽  
pp. bcr-2018-224785
Author(s):  
Takuro Nishiwaki ◽  
Norihiko Yamamoto ◽  
Yoshihumi Hirokawa ◽  
Yoshiyuki Takei
Keyword(s):  
Heart Failure ◽  
Hepatocellular Carcinoma ◽  
Rare Complication ◽  
Pacemaker Implantation ◽  
Cardiac Metastasis ◽  
Av Block ◽  
Complete Atrioventricular Block ◽  
Β Blocker ◽  
Complete Atrioventricular ◽  
Complete Av Block

A 72-year-old man, who had been diagnosed as having hepatocellular carcinoma (HCC) with multiple extrahepatic metastasis, complained a general fatigue which appeared 2 weeks before admission. Because bradycardia was detected on physical examination, ECG was performed which revealed the complete atrioventricular (AV) block. We stopped Ca-blocker and β-blocker, but the bradycardia persisted. He was admitted to our hospital for an emergent pacemaker implantation. On admission, he complained dyspnoea. After the surgery, he died due to deterioration of heart failure. The autopsy revealed cardiac metastasis of HCC on AV node, so it was suspected that cardiac metastasis caused the AV block. We thought that the cause of his death was the exacerbation of heart failure associated with bradycardia. It was likely that complete AV block as a very rare complication caused by cardiac metastasis of HCC influenced the prognosis of this patient.

scholarly journals CARDIOVASCULAR PATIENT WITH PERMANENT PACEMAKER DUE TO COMPLETE ATRIOVENTRICULAR BLOCK

2018 ◽  
Keyword(s):  
Heart Failure ◽  
Drug Therapy ◽  
Arterial Hypertension ◽  
Atrioventricular Block ◽  
Pacemaker Implantation ◽  
Permanent Pacemaker ◽  
Av Block ◽  
Complete Atrioventricular Block ◽  
Cardiac Pathology ◽  
Complete Atrioventricular

Permanent pacemaker implantation and medical therapy due to complete atrioventricular block and comorbid cardiac pathology are considered at an example of clinical case. Permanent pacemaker solved the problem of AV-block, however, drug therapy due to arterial hypertension, heart failure and dyslipidemia is not canceled and requires modification. Permanent pacemaker solved the problem of AV-block, however, drug therapy due to arterial hypertension, heart failure and dyslipidemia is not canceled and requires modification.

A technique for production of complete atrioventricular block in dogs

1991 ◽  
Vol 261 (4) ◽  
pp. H1312-H1316 ◽  
Author(s):  
T. K. Day ◽  
W. W. Muir
Keyword(s):  
Ventricular Arrhythmias ◽  
Complete Heart Block ◽  
Formaldehyde Solution ◽  
Av Block ◽  
Complete Atrioventricular Block ◽  
Special Equipment ◽  
Av Node ◽  
Reliable Technique ◽  
Complete Atrioventricular ◽  
Complete Av Block

A simple and reliable technique for producing complete atrioventricular (AV) block in dogs by the injection of a 38% formaldehyde solution into the area of the AV node is described. This technique, a modification of previous methods utilizing formaldehyde injection for the production of complete AV block, uses the coronary sinus as the major landmark. Complete heart block was produced in 20 of 20 dogs. The technique is simple and associated with few problems, does not require special equipment, is associated with little or no hemorrhage from the injection site, and does not enter a cardiac chamber. The only side effect noted was the development of ventricular arrhythmias in 2 of 20 dogs. A detailed description of the technique is included with comparisons to previous techniques utilizing injection of a 40% formaldehyde solution.

scholarly journals Permanent Pacemaker Implantation in a Patient with Takotsubo Cardiomyopathy and Complete Atrioventricular Block

2021 ◽  
Vol 2021 ◽  
pp. 1-5
Author(s):  
Toshihiro Terui ◽  
Masumi Iwai-Takano ◽  
Tomoyuki Watanabe
Keyword(s):  
Takotsubo Cardiomyopathy ◽  
Wall Motion ◽  
Pacemaker Implantation ◽  
Left Ventricular ◽  
Permanent Pacemaker ◽  
Av Block ◽  
Permanent Pacemaker Implantation ◽  
History Of ◽  
Complete Atrioventricular ◽  
Complete Av Block

This case report presents a patient with Takotsubo cardiomyopathy (TCM) and complete atrioventricular (AV) block who was treated with permanent pacemaker implantation. A 78-year-old woman with a history of hypertension presented with a 6-month history of palpitations. On initial evaluation, her heart rate was 40 beats/minute. Electrocardiography revealed a complete AV block and T-wave inversion in these leads: I, II, aVL, aVF, and V3–6. Echocardiography showed akinesis from the midventricle to the apex and hyperkinesis on the basal segments. The patient was diagnosed with TCM and complete AV block. Because improvement of TCM may subsequently improve the AV node dysfunction associated with TCM, the patient was admitted for treatment of heart failure without pacemaker implantation. The left ventricular (LV) abnormal wall motion improved gradually; however, the AV block persisted intermittently. On hospital day 14, a pause of 5–6 seconds without LV contraction was observed, and permanent pacemaker implantation was performed. On day 92, echocardiography revealed normal LV wall motion. However, electrocardiography revealed that the pacemaker rhythm with atrial sensing and ventricular pacing remained. Although specific degree of damage that may result from AV block associated with TCM is unknown, some of these patients require pacemaker implantation, despite improvement of abnormality in LV wall motion.

scholarly journals Complete heart block associated with Remdesivir in COVID-19: a case report

2021 ◽  
Vol 5 (7) ◽  
Author(s):  
Vijairam Selvaraj ◽  
Chirag Bavishi ◽  
Simaben Patel ◽  
Kwame Dapaah-Afriyie
Keyword(s):  
Atrial Fibrillation ◽  
Pacemaker Implantation ◽  
Av Block ◽  
Bundle Branch Block ◽  
Chronotropic Response ◽  
Case Summary ◽  
History Of ◽  
Electrocardiogram Ecg ◽  
Complete Atrioventricular ◽  
Complete Av Block

Abstract Background Since the pandemic began in 2020, Remdesivir has been widely used for the treatment of coronavirus disease-2019 (COVID-19). Here, we describe a case of a patient with COVID-19 who developed transient complete atrioventricular (AV) block and bradycardia after initiating treatment with Remdesivir. Case summary A 72-year-old male with a history of atrial fibrillation and lung cancer was hospitalized for COVID-19. Electrocardiogram (ECG) on admission demonstrated atrial fibrillation and right bundle branch block. He was started on a course of Dexamethasone and Remdesivir. Within 24 h of starting Remdesivir, he was noted to be in atrial fibrillation with ventricular rates between 30 and 40 b.p.m. On Day 5 of Remdesivir therapy, ECG demonstrated complete AV block. Having completed the Remdesivir regimen, during the next 48 h, he was closely monitored, and the AV block resolved spontaneously. As he remained asymptomatic and had an adequate chronotropic response with activity, pacemaker implantation was not recommended. Discussion Despite the widespread use of Remdesivir, there is little known information about its cardiac toxicity. Daily ECGs and close cardiac surveillance of patients who develop severe bradycardia or AV block are essential. Discontinuation of the medication usually results in the resolution of these cardiac disturbances.

Incidence and predictors of complete atrioventricular conduction recovery among patients with heart block

2020 ◽  
Author(s):  
Samet Yilmaz ◽  
Mehmet Kilinc ◽  
Mehmet Koray Adali ◽  
Ipek Buber ◽  
Dursun Dursunoglu
Keyword(s):  
Pacemaker Implantation ◽  
High Serum ◽  
Av Block ◽  
Clinical Factors ◽  
Coronary Syndrome ◽  
Younger Age ◽  
Tertiary Center ◽  
Β Blocker ◽  
Complete Atrioventricular

Aim: In this study, our aim was to determine clinical factors related to the recovery of the conduction system in patients presenting with atrioventricular (AV) block. Materials & methods: A total of 178 patients who were hospitalized at a tertiary center due to second- or third-degree AV block were retrospectively analyzed. Results: During hospital follow-up, 19.1% of patients had fully recovered from AV block. According to a logistic regression analysis; younger age (odds ratio [OR]: 0.950; 95% CI: 0.932–0.967; p < 0.001), presenting with acute coronary syndrome (OR: 18.863; 95% CI: 3.776–94.222; p < 0.001), β-blocker usage (OR: 12.081; 95% CI: 3.498–41.726; p < 0.001), high serum creatinine levels (OR: 4.338; 95% CI: 2.110–8.918; p < 0.001) and no calcification at the aortic valve (OR: 0.189; 95% CI: 0.050–0.679; p = 0.011) were found to be related to resolution of AV block. Conclusion: It is crucial to know the reversible causes of AV block to prevent unnecessary permanent pacemaker implantation.

scholarly journals The impact of complete atrioventricular block on in-hospital and long-term mortality in patients with ST-elevation myocardial infarction

2021 ◽  
Vol 10 (Supplement_1) ◽  
Author(s):  
L Savic ◽  
I Mrdovic ◽  
M Asanin ◽  
G Krljanac
Keyword(s):  
Heart Failure ◽  
Hospital Mortality ◽  
Heart Block ◽  
Independent Predictor ◽  
Av Block ◽  
St Elevation ◽  
Complete Atrioventricular ◽  
Complete Av Block ◽  
Long Term Mortality

Abstract Funding Acknowledgements Type of funding sources: None. Background/aim: Complete atrioventricular (AV) block is associated with worse in-hospital outcome in patients with ST-elevation myocardial infarction (STEMI), while whether it has an impact on long-term outcome is uncertain. The majority of previous studies that analyzed this issue are performed before introduction primary percutaneous coronary intervention (pPCI). The aim of this study was to analyse the incidence and the prognostic impact of complete AV block at admission on in-hospital and 6-year mortality in STEMI patients treated with pPCI. Method we analyzed 2863 consecutive STEMI patients without cardiogenic shock at admission. Clinical, laboratory and echocardiographic characteristics and prognosis were compared between patients with and without complete AV block at admission. Results Complete AV block at admission was registered in 134 (4.6%) patients; 117 (87.3%) patients with complete AV block had inferior infarction. In comparison without complete AV block, patients with complete AV block were older; they were more likely to have heart failure, lower blood pressure and lower creatinine clearance at admission, multi-vessel disease on initial coronary angiogram and lower pre-discharge left ventricular ejection fraction (EF). Temporary pacemaker was implanted in 68 (50%) patients with complete AV block. No patient underwent permanent pacemaker implantation. In-hospital mortality was significantly higher in patients with complete AV block than in patients without complete AV block: 17.9% vs 3.6%, respectively, p &lt; 0.001. In patients with heart block and inferior infarction in-hospital mortality was 13%,  whereas in patients with heart block and anterior infarction in-hospital mortality was 53%. When we analyze patients who were discharged alive from the hospital, we also find significantly higher long-term (6-year) mortality rate in those with complete AV block at admission vs patients without AV block: 7.8% vs 3.4% respectively, p &lt; 0.001 (Figure 1). The causes of death in patients with complete AV block during long-term follow up were cardiovascular, e.g. sudden death, reinfarction or worsening of heart failure. In Cox regression model complete AV block was an independent predictor for in-hospital and 6-year mortality: in-hospital mortality HR 2.54 85%CI 1.93-5.22, p = 0.011; six year mortality HR 1.61, 95CI 1,09-2.37, p = 0.017. Other independent predictors for both short- and long-term mortality were age, heart failure at admission, lower creatinine clearance at admission, EF and post-procedural flow TIMI &lt;3 thorugh infarct-related artery. Conclusion Complete AV block at admission is an independent predictor for in-hospital and long-term mortality in STEMI patients treated with primary PCI. Abstract Figure 1

Infra-Hissian complete AV block

2017 ◽  
Author(s):  
Hein Heidbuchel ◽  
Mattias Duytschaever ◽  
Haran Burri
Keyword(s):  
Atrioventricular Block ◽  
Av Block ◽  
Complete Atrioventricular Block ◽  
Complete Atrioventricular ◽  
Complete Av Block

This case examines infra-Hisian complete atrioventricular block with ventriculoatrial conduction

scholarly journals Dopamine and epinephrine for managing complete atrioventricular block due to nonreperfused acute inferior wall myocardial infarction in a rural hospital: A case report

2021 ◽  
Vol 9 ◽  
pp. 2050313X2199611
Author(s):  
Evelyne Sandjojo ◽  
Vanessa AMC Jaury ◽  
Yufi K Astari ◽  
Mahendria Sukmana ◽  
Rizky A Haeruman ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Case Report ◽  
Atrioventricular Block ◽  
Pacemaker Implantation ◽  
Uncontrolled Hypertension ◽  
Definitive Treatment ◽  
Inferior Wall ◽  
Complete Atrioventricular Block ◽  
History Of ◽  
Complete Atrioventricular

Inferior wall myocardial infarction occurs in approximately 50% of all myocardial infarctions. The most common conduction disorder of this disease is complete atrioventricular block. Immediate attention must be given to the myocardial infarction patients with conduction block due to the increased mortality rate in these patients. Temporary pacemaker implantation and permanent pacemaker implantation are recommended in complete atrioventricular block cases that do not improve with reperfusion. In this case report, a 64-year-old-female patient came to the emergency department of a rural General Hospital with complaints of epigastric pain, dizziness, nausea, and vomiting for 2 days before admission. She had uncontrolled hypertension without a history of diabetes mellitus, dyslipidemia, smoking, or a family history of heart disease. The electrocardiogram displayed an acute inferior wall myocardial infarction and complete atrioventricular block with escape junctional rhythm with a heart rate of 17 bpm. She was diagnosed with nonreperfused inferior wall myocardial infarction and a complete atrioventricular block. She was successfully treated with only dopamine and epinephrine as the definitive treatment because the patient refused to be referred to a tertiary hospital for percutaneous coronary intervention and pacemaker implantation due to financial reasons. Dopamine and epinephrine may be considered for complete atrioventricular block if transfer to a higher level of care is not feasible and as bridge therapy while waiting for transfer.

scholarly journals Acute Heart Failure and Complete AV Block in A Patient With Severe Covid-19 Pneumonia

2021 ◽  
Vol 05 (06) ◽  
Author(s):  
Silvio A ◽  
Hugo RZ ◽  
Alan GV ◽  
Juan RG ◽  
Adriana TM ◽  
...  
Keyword(s):  
Heart Failure ◽  
Acute Heart Failure ◽  
Av Block ◽  
Complete Av Block
Sign in / Sign up

Export Citation Format

Share Document